E. Bozzato

Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.

V. Préat, C. Bastiancich, G. Muccioli, 2022, International journal of pharmaceutics.

Combinational Drug-Loaded Lipid Nanocapsules for the Treatment of Cancer.

V. Préat, Arnaud M. Vigneron, Alessandra Lopes, 2019, International journal of pharmaceutics.

Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.

V. Préat, F. Danhier, B. Gallez, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Nanomedicine: A Useful Tool against Glioma Stem Cells

V. Préat, C. Bastiancich, E. Bozzato, 2020, Cancers.

Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment

V. Préat, G. Bastiat, F. Danhier, 2019, International journal of pharmaceutics.

Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review.

B. Newland, C. Bastiancich, E. Bozzato, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Mismatch between Bioluminescence Imaging (BLI) and MRI When Evaluating Glioblastoma Growth: Lessons from a Study Where BLI Suggested “Regression” while MRI Showed “Progression”

V. Préat, B. Manshian, B. Gallez, 2023, Cancers.

Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.

V. Préat, G. Bastiat, Umer Farooq, 2023, Biomaterials advances.